Sale!

CFL2 Gene Nemaline Myopathy Type 7 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The CFL2 Gene Nemaline Myopathy Type 7 NGS Genetic DNA Test is a cutting-edge genetic screening that identifies mutations in the CFL2 gene responsible for nemaline myopathy type 7, a rare inherited neuromuscular disorder. This comprehensive test utilizes next-generation sequencing technology to provide accurate detection of genetic variants associated with muscle weakness, respiratory complications, and developmental delays. The test is essential for individuals experiencing unexplained muscle weakness, delayed motor milestones, or with family history of neuromuscular conditions. At only $500 USD, this advanced genetic analysis offers precise diagnosis, enables early intervention strategies, and provides crucial information for family planning decisions. Results are delivered within 3-4 weeks using blood, extracted DNA, or FTA card samples.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

CFL2 Gene Nemaline Myopathy Type 7 NGS Genetic DNA Test

Comprehensive Genetic Screening for Neuromuscular Disorders

The CFL2 Gene Nemaline Myopathy Type 7 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for rare neuromuscular conditions. This advanced screening utilizes next-generation sequencing technology to identify mutations in the CFL2 gene, which encodes cofilin-2, a crucial protein involved in actin filament dynamics within muscle cells. When mutations occur in this gene, they disrupt normal muscle function, leading to the development of nemaline myopathy type 7—a severe form of congenital myopathy characterized by muscle weakness and respiratory complications.

What This Test Measures and Detects

This sophisticated genetic analysis specifically targets:

  • Comprehensive sequencing of the entire CFL2 gene coding region
  • Detection of point mutations, insertions, and deletions
  • Identification of pathogenic variants associated with nemaline myopathy type 7
  • Assessment of genetic markers for disease severity and progression
  • Analysis of inheritance patterns (autosomal recessive)

Who Should Consider This Genetic Test?

Clinical Indications and Symptoms

This test is particularly recommended for individuals presenting with:

  • Unexplained muscle weakness beginning in infancy or early childhood
  • Delayed motor milestones and developmental delays
  • Respiratory difficulties requiring ventilatory support
  • Feeding difficulties and failure to thrive in infancy
  • Family history of neuromuscular disorders or consanguinity
  • Abnormal muscle biopsy showing nemaline rods
  • Suspected congenital myopathy with characteristic clinical features

Significant Benefits of Genetic Testing

Comprehensive Diagnostic Advantages

Undergoing the CFL2 Gene Nemaline Myopathy Type 7 test provides numerous critical benefits:

  • Accurate Diagnosis: Provides definitive genetic confirmation of nemaline myopathy type 7
  • Early Intervention: Enables timely implementation of appropriate medical management
  • Family Planning: Offers crucial information for genetic counseling and reproductive decisions
  • Personalized Treatment: Guides development of targeted therapeutic approaches
  • Prognostic Information: Helps predict disease progression and potential complications
  • Research Contribution: Contributes to advancing understanding of rare neuromuscular disorders

Understanding Your Test Results

Interpretation and Clinical Implications

Your genetic test results will be carefully analyzed and interpreted by our team of certified genetic specialists:

  • Positive Result: Indicates the presence of pathogenic CFL2 gene mutations confirming nemaline myopathy type 7 diagnosis
  • Negative Result: Suggests absence of detectable CFL2 mutations, though other genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation
  • Carrier Status: Determines if individuals carry one copy of a mutated gene without showing symptoms

All results include comprehensive genetic counseling to ensure complete understanding and appropriate next steps for medical management.

Test Pricing and Availability

Test Description Price (USD)
CFL2 Gene Nemaline Myopathy Type 7 NGS Genetic DNA Test – Discount Price $500
CFL2 Gene Nemaline Myopathy Type 7 NGS Genetic DNA Test – Regular Price $700

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Testing Method: Next-Generation Sequencing (NGS) Technology
  • Specialty: Neurology and Genetics
  • Disease Category: Neurological Disorders

Pre-Test Requirements

To ensure optimal testing accuracy and comprehensive analysis, we require:

  • Complete clinical history of the patient
  • Genetic counseling session to document family pedigree
  • Informed consent for genetic testing
  • Appropriate sample collection following established protocols

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about neuromuscular symptoms affect your quality of life. Our CFL2 Gene Nemaline Myopathy Type 7 NGS Genetic DNA Test provides the definitive answers you need for proper diagnosis and management. With our discounted price of only $500 USD and comprehensive genetic counseling support, you can make informed decisions about your health and future.

Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take control of your genetic health with confidence and precision.